Health & Medicine

STAT+: AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion

Ali Nemati3 days ago29 sec read27 views0 listens

Insilico Medicine and Eli Lilly have entered into a commercialization deal worth up to $2.75 billion for developing AI-discovered drug candidates, highlighting the growing importance of AI in pharmaceutical research. This collaboration underscores the potential for AI technologies to accelerate drug discovery and development processes, offering significant opportunities for tech professionals in health tech. The success of this partnership could set a precedent for future collaborations between AI companies and pharmaceutical giants.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

[AINews] The Unreasonable Effectiveness of Closing the Loop

Claude Code Remote Control rollout announced by @claudeai. Qwen 3.5 Medium Model Series released by @Alibaba_Qwen. Cursor agents now ship "demos not diffs" as per @cursor_ai. Karpathy discusses CLIs as agent-native interface on Twitter. Meta and AMD...

Ali Nemati

E-Commerce & RetailFeb 2530 sec read

How IKEA got closer to its shoppers with new small-format stores, Best Buy partnership

IKEA announced plans for four new U.S. stores in 2026, including its first small-format stores that blend elements of larger stores into a smaller space, aiming to increase accessibility; it also launched a partnership with Best Buy to integrate IKEA...

Ali Nemati

AI & Machine LearningFeb 2526 sec read

Why do deep technical searches still take hours - and what actually fixes them?

The article discusses the inefficiencies in technical research workflows due to fragmented information retrieval from PDFs and other sources, leading to incomplete understanding and delayed decision-making. It proposes a structured approach involving...

Ali Nemati

GamingFeb 2525 sec read

New Xbox Leadership Confirms No Microsoft Pressure to Increase AI Use

New Xbox leaders Asha Sharma and Matt Booty assure there will be no pressure for developers to use AI, emphasizing a commitment to maintaining high-quality content over technological trends. This stance is significant as it reassures content creators...

Ali Nemati

AI & Machine LearningFeb 2529 sec read

Why Deep Research Fails Fast (and How to Stop Burning Time)

The article discusses common pitfalls in integrating deep AI research into products, highlighting issues like treating research as a black-box process and over-relying on single models without proper retrieval checks. It emphasizes the importance of ...

Ali Nemati

STAT+: AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion

Related Articles

[AINews] The Unreasonable Effectiveness of Closing the Loop

How IKEA got closer to its shoppers with new small-format stores, Best Buy partnership

Why do deep technical searches still take hours - and what actually fixes them?

New Xbox Leadership Confirms No Microsoft Pressure to Increase AI Use

Why Deep Research Fails Fast (and How to Stop Burning Time)